Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2000
08/16/2000CN1263464A Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
08/16/2000CN1263461A Pharmaceutical composition
08/16/2000CN1263454A Device and method for treatment of dysmenorrhea
08/16/2000CN1262949A Pure Chinese medicinal preparation for curing sterility and its preparation process
08/16/2000CN1262945A Preparation method of medicine Huanshen Xingnao Dan for curing encephalomyelopathy
08/16/2000CN1262943A Skin ointment with functions of relieving inflammation, alleviating pain and inhibiting cicatrization
08/16/2000CN1262942A Intravenous injection medicine for curing ischemic cerebrovascular disease and its preparing method
08/16/2000CN1262940A Preparation method of Chinese medicine for curing gastrosis
08/16/2000CN1262933A Soluble granules for curing vitreous opacity and vitreous hemorrhage and preparation method thereof
08/16/2000CN1262929A Medicine for curing schistosomiasis and its preparation method
08/16/2000CN1262927A Dihydroartemisinin preparation for controlling broad-spectrum malaria and its preparation method
08/16/2000CN1262926A Hot medicated compress preparation
08/16/2000CN1262925A Preparation method of microlipid granule for wrapping medicine
08/16/2000CN1262922A Cosmetic or skin-protecting composition containing at least one kind of alkynyl carbamate and polyol
08/16/2000CN1055417C Nucleus-shell structure protein high-molecule microball and its manufacturing method
08/16/2000CN1055414C Method for preparation of polymeric gas or air filled microballoons
08/16/2000CN1055413C Method for preparing composition suitable for injecting into vivo-blood vessel and body cavity
08/16/2000CN1055405C Capsule for curing thromboangitis
08/16/2000CN1055403C Medical ointment for treating scabies
08/16/2000CN1055402C Capsule for curing diabets mellitus
08/16/2000CN1055392C Drug composition for curing psoriasis and its medicinal use
08/16/2000CN1055389C Composition and application against senile plaque formed on sin and/or slow death
08/15/2000US6104950 Plaster structure for iontophoresis
08/15/2000US6103770 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds
08/15/2000US6103765 Methods for treating male erectile dysfunction
08/15/2000US6103757 Administering a benzofuran derivative to the human suffering from arrhythmia
08/15/2000US6103746 Methods and compositions for the protection of mitochondria
08/15/2000US6103742 Administering to said patient a therapeutically effective amount of an insulin sensitivity enhancer in combination with a statin compound to treat diabetes
08/15/2000US6103704 Topically administering a therapeutically effective dosage of a formulation which comprises hyaluronic acid and an antiinflammatory or anticarcinogenic agent; treatment of diseases and conditions of the skin and exposed tissue
08/15/2000US6103275 Systems and methods for topical treatment with nitric oxide
08/15/2000US6103274 Pharmaceutical, orally applicable composition
08/15/2000US6103271 Adding primary solution to first chamber, secondary solution to second chamber, forming interface at porous barrier, moving interface, forming microcapsules, isolating by filtration
08/15/2000US6103270 Methods and system for processing dispersible fine powders
08/15/2000US6103269 Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
08/15/2000US6103266 Film-forming gel comprising water insoluble alkyl cellulose or hydroxyalkyl cellulose, pharmacologically acceptable solvent, pharmaceutical
08/15/2000US6103265 Improved flow controllers for controlling passage of fluid through or around controller to form suspension or slurry with active agent within oral delivery system for delivering discrete units of active agent in admixture with fluid
08/15/2000US6103264 Process for preparing a controlled release composition
08/15/2000US6103263 Delayed pulse release hydrogel matrix tablet
08/15/2000US6103262 Composition capable of delivering acceptable bioavailability for up to twenty-four hours
08/15/2000US6103261 Opioid formulations having extended controlled release
08/15/2000US6103260 Antifoam oral solid dosage form preparations
08/15/2000US6103259 Process for the preparation of liposomes without the use of an organic solvent
08/15/2000US6103257 Hard candy matrix in which tetracaine is dispersed.
08/15/2000US6103256 Intravaginal drug delivery device
08/15/2000US6103254 Methods for sterilizing male mammals
08/15/2000US6103253 Films which can be produced thereof are pressure-sensitive adhesive, water-insoluble, and at least partially biodegradable; cellulose derivative or a homopolymer or a copolymer of hydroxybutanoic acid or hydroxyvaleric acid.
08/15/2000US6103219 Pharmaceutical excipient having improved compressibility
08/15/2000US6103218 Therapeutic nasal spray administered composition containing feverfew
08/15/2000US6103217 Polymerized liposomes comprise a plurality of polymerized diacetylene lipid monomers comprising a polymerizable group; and one or more ligands selected from the group consisting of proteins, carbohydrates, nucleic acids, and gangliosides
08/15/2000US6103216 Hepatocyte-selective oil-in-water emulsion
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000US6102205 Prepolymer compositions comprising an antimicrobial agent
08/15/2000CA2287056C Orally administrable solid ribavirin dosage forms and process for making them
08/15/2000CA2165071C Ocular insert with anchoring protrusions
08/15/2000CA2153391C Inducing cytotoxic t lymphocyte responses
08/15/2000CA1341087C Medicaments including hyaluronic acid as a drug delivery system
08/10/2000WO2000046182A1 Method of preparing alkylated salicylamides
08/10/2000WO2000046147A2 Therapeutic calcium phosphate particles and methods of manufacture and use
08/10/2000WO2000045878A2 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor
08/10/2000WO2000045868A1 Thermo-reversible polymer for intralumenal implant
08/10/2000WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity
08/10/2000WO2000045848A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
08/10/2000WO2000045847A1 Novel mucosal delivery system
08/10/2000WO2000045846A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
08/10/2000WO2000045845A2 Liposome composition and method for administration of a radiosensitizer
08/10/2000WO2000045841A2 Human papilloma virus vaccine formulations
08/10/2000WO2000045830A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/10/2000WO2000045826A1 Process for making ceramic microspheres
08/10/2000WO2000045821A1 Analgesic agent tetralgin and method for preparing the same
08/10/2000WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
08/10/2000WO2000045807A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
08/10/2000WO2000045801A2 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
08/10/2000WO2000045798A1 Method of manufacture for transdermal matrices
08/10/2000WO2000045797A1 Method of manufacture for transdermal matrices
08/10/2000WO2000045796A1 Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045794A1 Edible coating composition
08/10/2000WO2000045793A1 Ph independent extended release pharmaceutical formulation
08/10/2000WO2000045792A1 Hydrogel particle formulations
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045790A2 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
08/10/2000WO2000045789A1 Anti-plaque emulsions and products containing same
08/10/2000WO2000045786A1 Cholesterol sulfate compositions for enhancement of stratum corneum function
08/10/2000WO2000045785A1 Dermatological patch
08/10/2000WO2000045770A2 Compressed lecithin preparations
08/10/2000WO2000045734A1 Controlled release composite
08/10/2000WO2000045648A1 Method of preparing microparticles of phytosterols or phytostanols
08/10/2000WO2000033861A3 Pharmaceutical compositions containing protein-disulfide isomerases
08/10/2000WO2000028975A3 Improved chemical process and pharmaceutical formulation
08/10/2000WO2000027372A8 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
08/10/2000WO2000025751A3 Improved amoxycillin and clavulanate composition
08/10/2000WO2000024360A3 Preparation and use of solidified oils
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000016746A8 Immunogenic liposome compositions
08/10/2000WO2000013665A9 Controlled release drug delivery
08/10/2000WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
08/10/2000WO1999008706A8 Recombinant porcine adenovirus vector
08/10/2000DE19926714A1 Composition for producing hard capsules with a low moisture content comprises water, hydroxypropyl methylcellulose, gellan gum, sodium citrate, glycerol and sucrose fatty acid ester
08/10/2000DE19904847A1 Öl-in-Wasser-Mikroemulsion enthaltend Alkanolammonium-Salze der Alkylsulfate und/oder Alkylpolyalkylenglykolethersulfate Oil-in-water microemulsion containing alkanol ammonium salts of alkyl sulfates and / or alkylpolyalkyleneglycolethersulfates
08/10/2000DE19904785A1 Verfahren zur Herstellung von stabilem Alginatmaterial Process for the preparation of stable alginate
1 ... 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 ... 2991